Palatin Technologies Inc (PTN)
1.69
-0.04
(-2.31%)
USD |
NYAM |
Apr 25, 13:42
Palatin Technologies Max Drawdown (5Y): 96.46% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 96.46% |
February 29, 2024 | 96.46% |
January 31, 2024 | 96.46% |
December 31, 2023 | 96.46% |
November 30, 2023 | 96.46% |
October 31, 2023 | 96.46% |
September 30, 2023 | 96.46% |
August 31, 2023 | 95.51% |
July 31, 2023 | 95.51% |
June 30, 2023 | 94.95% |
May 31, 2023 | 94.88% |
April 30, 2023 | 94.59% |
March 31, 2023 | 94.59% |
February 28, 2023 | 94.59% |
January 31, 2023 | 94.59% |
December 31, 2022 | 94.59% |
November 30, 2022 | 90.61% |
October 31, 2022 | 89.51% |
September 30, 2022 | 89.51% |
August 31, 2022 | 88.80% |
July 31, 2022 | 83.84% |
June 30, 2022 | 83.48% |
May 31, 2022 | 80.12% |
April 30, 2022 | 79.00% |
March 31, 2022 | 79.00% |
Date | Value |
---|---|
February 28, 2022 | 79.00% |
January 31, 2022 | 79.17% |
December 31, 2021 | 79.17% |
November 30, 2021 | 79.17% |
October 31, 2021 | 79.17% |
September 30, 2021 | 79.17% |
August 31, 2021 | 79.17% |
July 31, 2021 | 79.17% |
June 30, 2021 | 79.17% |
May 31, 2021 | 79.17% |
April 30, 2021 | 79.17% |
March 31, 2021 | 79.17% |
February 28, 2021 | 79.17% |
January 31, 2021 | 79.17% |
December 31, 2020 | 79.17% |
November 30, 2020 | 79.17% |
October 31, 2020 | 79.17% |
September 30, 2020 | 79.17% |
August 31, 2020 | 79.17% |
July 31, 2020 | 79.17% |
June 30, 2020 | 79.17% |
May 31, 2020 | 79.17% |
April 30, 2020 | 79.17% |
March 31, 2020 | 79.17% |
February 29, 2020 | 79.17% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
79.00%
Minimum
Feb 2022
96.46%
Maximum
Sep 2023
84.74%
Average
79.17%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
Oragenics Inc | 98.92% |
Outset Medical Inc | -- |
Ligand Pharmaceuticals Inc | 77.41% |
Galectin Therapeutics Inc | 88.76% |
ADMA Biologics Inc | 84.77% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -54.32 |
Beta (5Y) | 0.9269 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.39% |
Historical Sharpe Ratio (5Y) | -0.5003 |
Historical Sortino (5Y) | -1.090 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.77% |